Time to PSA nadir independently predicts overall survival in metastatic hormone sensitive prostate cancer patients treated with androgen deprivation therapy

INTRODUCTION: The purpose of this study was to evaluate the relationship between the kinetics of PSA decline after androgen deprivation therapy (ADT) initiation and overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (HSPC). METHODS: We identified a cohort of metastatic HS...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Choueiri, Toni K., Xie, Wanling, D’Amico, Anthony V., Ross, Robert W., Hu, Jim C., Pomerantz, Mark, Regan, Meredith M., Taplin, Mary-Ellen, Kantoff, Philip W., Sartor, Oliver, Oh, William K.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2931827/
https://ncbi.nlm.nih.gov/pubmed/19152438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24064
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars